Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mandeli

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Journal of the National Cancer Institute|June 8, 2000
Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long- term remission of liver metastases in a mouse modelO Martinet, V Ermekova, J Q Qiao, et al.
Cancer Treatment Reviews|March 1, 1991
Hexamethylmelamine for the treatment of ovarian cancer--the Mount Sinai experienceH W Bruckner, C Cohen, J Mandeli, et al.
Comprehensive Psychiatry|November 1, 1988
Histories of substance abuse in patients with postpsychotic depressionsS G Siris, J M Kane, K Frechen, et al.
Archives of General Psychiatry|August 1, 1989
Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndromeE Shapiro, A K Shapiro, G Fulop, et al.
American Journal of Obstetrics and Gynecology|April 1, 1996
Phase I/II study of PIXY321 in combination with cyclophosphamide and carboplatin in the treatment of ovarian cancerC D Runowicz, J Mandeli, J L Speyer, et al.
Cancer Investigation|January 1, 1993
Combined modality therapy increasing local control of pancreatic cancerH W Bruckner, S Kalnicki, J Dalton, et al.
Cancer|June 8, 2001
A Phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinomaA C Ferrari, A Chachoua, H Singh, et al.
Gene Therapy|June 1, 2002
T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancerO Martinet, C M Divino, Y Zang, et al.
Journal of the National Cancer Institute|October 23, 1997
Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancerA C Ferrari, N N Stone, J N Eyler, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I study of subcutaneously-administered bacterially-synthesised recombinant human granulocyte-macrophage colony-stimulating factorG K Schwartz, J J Collins, A Galazka, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of the National Cancer Institute|June 8, 2000
Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long- term remission of liver metastases in a mouse modelO Martinet, V Ermekova, J Q Qiao, et al.
Cancer Treatment Reviews|March 1, 1991
Hexamethylmelamine for the treatment of ovarian cancer--the Mount Sinai experienceH W Bruckner, C Cohen, J Mandeli, et al.
Comprehensive Psychiatry|November 1, 1988
Histories of substance abuse in patients with postpsychotic depressionsS G Siris, J M Kane, K Frechen, et al.
Archives of General Psychiatry|August 1, 1989
Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndromeE Shapiro, A K Shapiro, G Fulop, et al.
American Journal of Obstetrics and Gynecology|April 1, 1996
Phase I/II study of PIXY321 in combination with cyclophosphamide and carboplatin in the treatment of ovarian cancerC D Runowicz, J Mandeli, J L Speyer, et al.
Cancer Investigation|January 1, 1993
Combined modality therapy increasing local control of pancreatic cancerH W Bruckner, S Kalnicki, J Dalton, et al.
Cancer|June 8, 2001
A Phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinomaA C Ferrari, A Chachoua, H Singh, et al.
Gene Therapy|June 1, 2002
T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancerO Martinet, C M Divino, Y Zang, et al.
Journal of the National Cancer Institute|October 23, 1997
Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancerA C Ferrari, N N Stone, J N Eyler, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I study of subcutaneously-administered bacterially-synthesised recombinant human granulocyte-macrophage colony-stimulating factorG K Schwartz, J J Collins, A Galazka, et al.
Pageof 6